InvestorsHub Logo
icon url

uvaphd

02/17/19 10:21 PM

#76054 RE: rrao11 #76053

Not in the short term: ED process will generate sufficient revenues to fund all operations in 2019. Let’s let CaverStem and Femcelz proliferate for a couple years—and THEN consider selling them off (for a BIG premium).